J-105859

Subscribe to Selected New Research on J-105859

1 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure in first source

Also Known As:

((+)-(5S,6R,7R)-2-isopropylamino-7-(4-methoxy-2-(2R))-3-methoxy-2-methylpropyl)-5-(3,4-methylenedioxyphenyl)cyclopenteno(1,2-b)pyridine-6-carboxylic acid

Bio-Agent Context: Research Results

Organic Chemicals: 40

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Pyridines: 26

J-105859: 1

Related Diseases

1.	Hypertension (High Blood Pressure) 12/01/2000 - "CONCLUSION: J-105859 is a selective, potent, orally active ETA-selective antagonist ETA antagonists may reduce morbidity as well as mortality in salt-sensitive hypertension." Get all the results and reference details, order at left...
1 Diseases and 1 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>